Renalytix AI plc (AIM: RENX), a developer of artificial intelligence enabled clinical diagnostics for kidney disease, announces it will be presenting at the Cowen 40th Annual Health Care Conference taking place on March 1-4, 2020, at the Boston Marriott Copley Place in Boston, Massachusetts.
NEW YORK, March 2, 2020 /PRNewswire/ -- Renalytix AI plc (AIM: RENX), a developer of artificial intelligence enabled clinical diagnostics for kidney disease, announces it will be presenting at the Cowen 40th Annual Health Care Conference taking place on March 1-4, 2020, at the Boston Marriott Copley Place in Boston, Massachusetts. The conference brings together top institutional investors and leading companies operating in the Health Care space. James McCullough, CEO of RenalytixAI, will be presenting on Tuesday, March 3 at 8:40am - 9:10am EST in Dartmouth, located on the 3rd floor, breakout: Exeter, 3rd floor. The presentation will be made available on the Company’s website shortly after, which can be located here: https://renalytixai.com/investors/company-presentation/. No new material or trading information will be provided. About Kidney Disease About RenalytixAI View original content:http://www.prnewswire.com/news-releases/renalytixai-ceo-to-speak-at-the-40th-annual-cowen-health-care-conference-301014632.html SOURCE RenalytixAI | ||
Company Codes: LSE:RENX |